Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3 (Q79222918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Direct interferon-γ-mediated protection caused by a recombinant coxsackievirus B3 (English)

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

26 March 2024

1

Andreas Henke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Roland Zell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ulrike Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Axel Stelzner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585336

26 March 2024

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

25 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585336

full work available at URL

26 March 2024

https://api.elsevier.com/content/article/PII:S0042682203005385?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

https://api.elsevier.com/content/article/PII:S0042682203005385?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

26 March 2024

315

2

335–44

25 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14585336

26 March 2024

volume

315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

335-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14585336%20AND%20SRC:MED&resulttype=core&format=json

Engineering poliovirus as a vaccine vector for the expression of diverse antigens

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Selective delivery of nitric oxide to a cellular target: a pseudosubstrate-coupled dinitrosyl-iron complex inhibits the enteroviral protease 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Nitric oxide and Coxsackievirus B3 myocarditis: differential expression of inducible nitric oxide synthase in mouse heart after infection with virulent or attenuated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Coxsackie B virus infection and onset of childhood diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Cytokines produced early in picornavirus infection reflect resistance or susceptibility to disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Expression of inducible nitric oxide synthase in experimental viral myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Recombinant Interferons beta and gamma have a higher antiviral activity than interferon-alpha in coxsackievirus B3-infected carrier state cultures of human myocardial fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Expression of an antigenic adenovirus epitope in a group B coxsackievirus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

The immune system in viral myocarditis: maintaining the balance

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

From interference to interferon: a brief historical introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Nitric oxide inhibits viral replication in murine myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

The role of B lymphocytes in coxsackievirus B3 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Molecular packing in virus crystals: geometry, chemistry, and biology

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

An antiviral mechanism of nitric oxide: inhibition of a viral protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Occurrence of coxsackievirus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Viral myocarditis: identification of five differentially expressed genes in coxsackievirus B3-infected mouse heart

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Nitric oxide inhibition of coxsackievirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Interferon-gamma: biology and role in pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

EPR characterization of molecular targets for NO in mammalian cells and organelles

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900538-5

7 January 2021

Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury

11

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis

26 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

Enteroviruses in human disease

26 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice

26 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice

26 March 2024

41

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5

Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera

26 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/S0042-6822(03)00538-5